作者：
Briggs, Andrew H. [1]
;
Baker, Timothy [2]
;
Risebrough, Nancy A. [3]
;
Chambers, Mike [4]
;
Gonzalez-McQuire, Sebastian [5]
;
Ismaila, Afisi S. [6]
;
Exuzides, Alex [7]
;
Colby, Chris [8]
;
Tabberer, Maggie [9]
;
Muellerova, Hana [10]
;
Locantore, Nicholas ;
Rutten-van Molken, Maureen P. M. H. ;
Lomas, David A.
作者单位：
ICON Plc, San Francisco, CA USA
[1]
GlaxoSmithKline Res & Dev Ltd, Value Evidence & Outcomes, Uxbridge, Middx, England
[2]
GlaxoSmithKline Res & Dev Ltd, Worldwide Epidemiol, Uxbridge, Middx, England
[3]
Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland
[4]
UCL, London, England
[5]
ICON Plc, Toronto, ON, Canada
[6]
GlaxoSmithKline Res & Dev Ltd, Value Evidence & Outcomes, Res Triangle Pk, NC USA
[7]
ICON Plc, Morristown, NJ USA
[8]
Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[9]
GSK, Global Market Access & Healthcare Solut, Brentford, England
[10]
发布时间
2018-01-30
换一批
